ロード中...
Can Neuron Specific Enolase Be a Diagnostic Biomarker for Neuronal Injury in COVID-19?
Neuron specific enolase (NSE) is a biomarker for neuronal injury. However, increased levels in cerebrospinal fluid (CSF) and serum is associated with the clinical outcome in patients with head injury, ischemic stroke, intracerebral hemorrhage, cardiac arrest, anoxic encephalopathy, encephalitis, bra...
保存先:
| 出版年: | Cureus |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cureus
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7673275/ https://ncbi.nlm.nih.gov/pubmed/33214960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.11033 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|